Sinovac Biotech Ltd (SVA) — Free Cash Flow Generation Index
Sinovac Biotech Ltd (SVA) has a Free Cash Flow Generation Index of 0.64x as of December 2023. Free cash flow of $93.26 Million represents 1% of operating cash flow ($146.01 Million). Read SVA liabilities breakdown for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Sinovac Biotech Ltd Free Cash Flow Generation Index (2007–2023)
Historical FCF Generation Index trend for Sinovac Biotech Ltd across 12 annual periods. Explore Sinovac Biotech Ltd capital spending ratio to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for Sinovac Biotech Ltd (2007–2023)
Year-by-year Free Cash Flow Generation Index for Sinovac Biotech Ltd. For the full company profile including market capitalisation, see SVA market cap overview.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2023 | -0.39x | $-41.69 Million | $106.02 Million | $145.69 Million | ▼ -141.3% |
| 2021 | 0.95x | $14.63 Billion | $15.35 Billion | $719.98 Million | ▲ +29.9% |
| 2020 | 0.73x | $351.66 Million | $479.31 Million | $127.65 Million | ▲ +0.8% |
| 2019 | 0.73x | $28.45 Million | $39.07 Million | $10.63 Million | ▲ +148.2% |
| 2018 | 0.29x | $2.33 Million | $7.94 Million | $5.61 Million | ▼ -63.4% |
| 2017 | 0.80x | $47.84 Million | $59.76 Million | $11.91 Million | ▲ +409.9% |
| 2015 | -0.26x | $-1.09 Million | $4.21 Million | $5.30 Million | ▼ -425.2% |
| 2013 | 0.08x | $443.00K | $5.58 Million | $5.13 Million | ▲ +172.8% |
| 2011 | -0.11x | $-1.52 Million | $13.94 Million | $15.46 Million | ▼ -112.0% |
| 2009 | 0.91x | $44.09 Million | $48.41 Million | $4.32 Million | ▲ +46.6% |
| 2008 | 0.62x | $6.53 Million | $10.50 Million | $3.98 Million | ▲ +45.0% |
| 2007 | 0.43x | $1.85 Million | $4.32 Million | $2.47 Million | — |